LFB BIOMANUFACTURING offers development services, from pre-clinical to clinical stages : cell line development and banking, process development and scale-up. LFB’s proprietary platform EMABling® allows LFB BIOMANUFACTURING to propose specific developments for high-ADCC monoclonal antibodies.